Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
about
Overexpression of the ATP binding cassette gene ABCA1 determines resistance to Curcumin in M14 melanoma cellsLipids and the endothelium: bidirectional interactionsHeparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complicationsLXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1CCR2 modulates inflammatory and metabolic effects of high-fat feedingEffects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.Hyperhomocysteinemia potentiates hyperglycemia-induced inflammatory monocyte differentiation and atherosclerosis.Molecular mechanisms of diabetic cardiovascular disease.Aggressive very low-density lipoprotein (VLDL) and LDL lowering by gene transfer of the VLDL receptor combined with a low-fat diet regimen induces regression and reduces macrophage content in advanced atherosclerotic lesions in LDL receptor-deficienApolipoprotein E4 exaggerates diabetic dyslipidemia and atherosclerosis in mice lacking the LDL receptor.Fetal macrosomia related to maternal poorly controlled type 1 diabetes strongly impairs serum lipoprotein concentrations and composition.Effect of functional sympathetic nervous system impairment of the liver and abdominal visceral adipose tissue on circulating triglyceride-rich lipoproteins.Clinical use and pathogenetic basis of laboratory tests for the evaluation of primary arterial hypertension.Effect of Korean Red Ginseng treatment on the gene expression profile of diabetic rat retina.Triglycerides and disease.Mouse models for studies of cardiovascular complications of type 1 diabetes.Type 1 diabetes promotes disruption of advanced atherosclerotic lesions in LDL receptor-deficient mice.Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic micePredictors of Cognitive Decline in Older Adult Type 2 Diabetes from the Veterans Affairs Diabetes Trial.Analysis of lipoprotein profiles of healthy cats by gel-permeation high-performance liquid chromatography.Diabetes and increased lipid peroxidation are associated with systemic inflammation even in well-controlled patients.Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions.Relapsing-remitting multiple sclerosis patients display an altered lipoprotein profile with dysfunctional HDL.Antidiabetic Effect of Fresh Nopal (Opuntia ficus-indica) in Low-Dose Streptozotocin-Induced Diabetic Rats Fed a High-Fat Diet.PPAR agonists for the treatment of cardiovascular disease in patients with diabetes.Post-transcriptional mechanisms are responsible for the reduction in lipoprotein lipase activity in cardiomyocytes from diabetic rat heartsReduced Antioxidant Potential of LDL Is Associated With Increased Susceptibility to LDL Peroxidation in Type II Diabetic Patients.Lipaemic plasma induces haemolysis in resuspended red cell concentrate.Body weight modulates cholesterol metabolism in non-insulin dependent type 2 diabetics.Age-related changes in fatty acids in obese offspring of streptozotocin-induced diabetic rats.Treatment with high-dose simvastatin reduces secretion of apolipoprotein B-lipoproteins in patients with diabetic dyslipidemia.The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus.The Q/E27 polymorphism in the beta2-adrenoceptor gene is associated with increased body weight and dyslipoproteinaemia involving triglyceride-rich lipoproteins.Twelve Weeks of Medium-Intensity Exercise Therapy Affects the Lipoprotein Profile of Multiple Sclerosis Patients.Exposure to High Glucose Concentration Decreases Cell Surface ABCA1 and HDL Biogenesis in Hepatocytes.Evidence of increased secretion of apolipoprotein B-48-containing lipoproteins in subjects with type 2 diabetes.Insulin resistance, lipid and fatty acid concentrations in 867 healthy Europeans. European Group for the Study of Insulin Resistance (EGIR).Comparison of ADA and WHO screening methods for diabetes mellitus in obese patients. American Diabetes Association.Hypertriglyceridemia in Diabetes Mellitus: Implications for Pediatric Care.Polymorphisms in the insulin response element of APOC-III gene promoter influence the correlation between insulin and triglycerides or triglyceride-rich lipoproteins in humans
P2860
Q21245718-296DF7E7-EFC2-4012-8ACF-B3F16B42B19DQ26860086-786CF444-8F64-41FE-8DD8-EC9F9CD98571Q28213716-24B3C57B-C1CE-4548-B40D-A24F3CA08F04Q28245597-62C8567C-D6F0-4BCD-A527-063EBDE91284Q29622869-0FE623A8-5A0A-40F5-BCE1-53515D30D6C8Q33727061-A7E9BB36-B8E2-47FA-8E22-AFB950D51E9AQ34545440-88FAF59D-686D-4CFD-BC4D-D544166DDD24Q34989681-54835FE5-42E0-4488-A674-B50C8FBC0FE6Q35088381-3FFA824F-E80C-48DE-8DE1-69EECA7BC0FBQ35179999-677DF177-43D9-4E2D-875B-B5C17B75F92CQ35395461-0212BE1C-561A-496C-AD1B-E0B97DC9B551Q36323752-A77036C7-90F3-4A72-A400-BEDC0B4CE06AQ36359500-5717EB2A-EF6A-4BEC-B5FE-F78F92ED2879Q36437781-73F9C1FD-CD52-4CEF-B53C-F41856B20EA1Q36683565-CD0D0F00-7AD1-47B9-8067-B490C5D9A43AQ36766171-B549D4E1-D89F-4F20-8023-740AA3D38C8FQ36883079-4ABF0D69-D064-4882-B510-0A11024F1F38Q37202057-5EF99B97-868A-4090-9FB8-94B9D1258781Q37239814-93EDA488-671C-4079-B0AD-2DC3DE4B9CDFQ37317898-74C8D6BC-BC14-4433-9E2A-B031489D0D6FQ37431527-E0156038-02F0-4247-9AD8-0CC083AC7E81Q37486465-5B3E8584-108C-44E3-8904-3D58ADC5D93DQ37661249-30A78F5C-687C-49C6-9C1D-908851165618Q37681939-DC4953FE-C3A6-4E47-8782-1ED4B84101E2Q37996437-BF06E739-6551-4C26-846F-3CBAB4E18D16Q42821733-F3AA46FC-8AF0-4DF4-9B4F-3AA022AE53FEQ43114689-6C139070-4104-4760-91B9-1E7364330EDFQ43984272-3401A2B3-0CED-4C10-9B07-9BDB7DA0F1FDQ43990197-C492EE3B-4EE4-4A41-AD26-299EC5F72DF8Q44053882-D3587632-0F2E-4741-BA78-3F78FBC9888EQ46703453-71FC968E-5BFE-4E21-AF61-A9318D5EE688Q46781809-255AD335-3F61-40D9-924D-B7E127C851DFQ47235233-78DB2333-BDD4-4910-8818-29F1023B4B6CQ47742710-88141834-E074-4406-AF4F-47A8C59022B0Q49703070-941422CE-4DC4-4B08-B0A4-8758709737FEQ51476370-88F4844C-B96A-40B8-884E-4CB62A937E9BQ51559072-DB0BC90C-0153-49A2-BA95-BBF8A4598E66Q51561727-E5EFD945-AFD9-4127-AEE3-CF213F17333CQ55176268-B52B921C-82E2-4270-A442-427EB5B50D11Q57605929-E017F2ED-C38A-4279-8C0E-5E61058EEB37
P2860
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 1991
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
@en
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
@nl
type
label
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
@en
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
@nl
prefLabel
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
@en
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
@nl
P356
P1433
P1476
Lipoprotein physiology in nondiabetic and diabetic states. Relationship to atherogenesis.
@en
P2093
Ginsberg HN
P304
P356
10.2337/DIACARE.14.9.839
P407
P577
1991-09-01T00:00:00Z